| Identification | |
| Name: | Trityl olmesartan |
| Synonyms: | 1H-Imidazole-5-carboxylicacid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;Trityl olmesartan medoxomil; |
| CAS: | 144690-92-6 |
| Molecular Formula: | C48H44N6O6 |
| Molecular Weight: | 800.91 |
| InChI: | InChI=1/C48H44N6O6/c1-5-17-41-49-43(47(3,4)57)42(45(55)58-31-40-32(2)59-46(56)60-40)53(41)30-33-26-28-34(29-27-33)38-24-15-16-25-39(38)44-50-51-52-54(44)48(35-18-9-6-10-19-35,36-20-11-7-12-21-36)37-22-13-8-14-23-37/h6-16,18-29,57H,5,17,30-31H2,1-4H3 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.26 g/cm3 |
| Refractive index: | 1.648 |
| Appearance: | Off-White to White Powder |
| Usage: | Olmesartan medoxomil analog as angiotensin II antagonist. |
| Safety Data | |
 |
|
